Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.393NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.110NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.110NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.434NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.434NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.181NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.181NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.6.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.511NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.511NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.428.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.428.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.506NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.506NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.482NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.482NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.335NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.335NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAZNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.85NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.85NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.65NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.11.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDLNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDLNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used